Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver DiseaseManuel Soto‐Catalán, Sebastián Mas|International Journal of Molecular Sciences|2024Cited by 37
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob MiceLucas Opazo-Ríos, Sebastián Mas|International Journal of Molecular Sciences|2022Cited by 14